Auson Pharmaceuticals announced that it has received CNY 100 million in funding from Deyi Capital, China Merchants Securities Co., Ltd., Hangzhou Kaitai Capital Co., Ltd., Chobe Capital, Shanghai Qiaobei Investment Management Partnership Enterprise (L.P.), Shanghai Zhangke Herun Venture Capital Co., Ltd.

Auson Pharmaceuticals announced that it has received CNY 100 million in its Series B round of funding led by Deyi Capital on August 5, 2022. The transaction included participation from China Merchants Securities Co., Ltd. (SHSE:600999), Chobe Capital, returning investors Hangzhou Kaitai Capital Co., Ltd., Shanghai Qiaobei Investment Management Partnership Enterprise (L.P.), Shanghai Zhangke Herun Venture Capital Co., Ltd.